Research

PUBLICATIONS

Chapters

  1. Schlossberg D, Jeyarajah DR, Rege R. Biliary Infection: Cholecystitis, Cholangitis.  Current Therapy of Infectious Disease, 2nd edition; Mosby, Inc.; 157-159; 2000.
  2. Cameron JL, Jeyarajah DR, Rege RV.  Open Cholecystectomy: When Is It Indicated? Current Surgical Therapy; 7th edition; Mosby, Inc.; 441-445; 2001.
  3. Shackelford RT, Jeyarajah DR, Rege R. Operative Management of Cholangitis, Choledocholithiasis and Bile Duct Strictures in the septic patient. Shackleford's Surgery of the Alimentary Tract, 5th edition;W.B. Saunders Co., 219-228, 2002.
  4. Jeyarajah DR, Harford WV.  Diverticula of the Hypopharynx, Esophagus, Stomach, Jejunum and Ileum.  Sleisenger and Fordtran's Gastrointestinal and Liver Disease; 7th Edition; Saunders, 359-368, 2002.
  5. Jeyarajah DR, Harford WV.  Abdominal Hernias and Their Complications, Including Gastric Volvulus. Sleisenger and Fordtran's Gastrointestinal and Liver Disease; 7th Edition; Saunders, 369-385. 2002.
  6. Lu CY, Vazquez MA, Kielar ML, Jeyarajah DR, Zhou XJ.  Renal TransplantationKelley's Textbook of Internal Medicine; 4th Edition; HD Humes, 1297-1304, 2002.
  7. Rege RV, Jeyarajah DR.  Antibiotic Selection in Biliary Surgery.   Current Surgical Therapy, 8th edition; Mosby, Inc.; 2005.
  8. Jeyarajah DR, Harford WV.  Diverticula of the Hypopharynx, Esophagus, Stomach, Jejunum and Ileum.  Sleisenger and Fordtran's Gastrointestinal and Liver Disease; 8th Edition; Saunders, 2006.
  9. Jeyarajah DR, Harford WV.  Abdominal Hernias and Their Complications, Including Gastric Volvulus. Sleisenger and Fordtran's Gastrointestinal and Liver Disease; 8th Edition; Saunders, 369-385. 2006.
  10. Jeyarajah DR. ACCP Critical Care Board Review Course Syllabus 2005. American College of Chest Physicians, 2005.
  11. Jeyarajah DR, Harford WV. Diverticula of the Hypopharynx, Esophagus, Stomach, Jejunum and Ileum. Sleisenger and Fordtran's Gastrointestinal and Liver Disease; 9th Edition; Saunders.
  12. Jeyarajah DR, Harford WV. Abdominal Hernias and Their Complications, Including Gastric Volvulus. Sleisenger and Fordtran's Gastrointestinal and Liver Disease; 9th Edition; Saunders.

Journals

  1. Falcone PA, Barrall DT, Jeyarajah DR, Grossman JA. Non-operative management of full-thickness intravenous extravasation injuries in premature neonates using enzymatic debridement. Ann Plast Surg. 22 (2):146-9, 1989.
  2. Jeyarajah DR, Thistlethwaite JR, Jr. General aspects of cytokine release syndrome: timing and incidence of symptoms. Transplant Proc. 25 (2 suppl 1): 16-20, 1993 Apr.
  3. Jeyarajah DR, Schmeisser FS, Josephson MA, Sohn DG, Thistlethwaite JR, Jr. Low-dose anti-CD3 therapy provides long term graft survival in a Lewis rate to C57BL/6 xeno-transplantation model. Transplant Proc. 26 (2):771-3, 1994 Apr.
  4. Jeyarajah DR, Schmeisser FS, Thistlethwaite JR, Jr.  Prolongation of skin xenograft survival with concomitant donor bone marrow transplantation.  Transplant Proc. 26 (3):1201-2, 1994 Jun.
  5. Alegre M-L, Peterson Lj, Xu D, Sattar HA, Jeyarajah DR, Kowalkowski K, Thistlethwaite JR, Jr., Zivin RA, Jolliffe L, Bluestone JA.  A non-activating "humanized" anti-CD3 monoclonal antibody retains immunosuppressive properties in vivo. Transplantation.57 (11):1537-43, 1994.
  6. Smith DM, Bluestone JA, Jeyarajah DR, Newberg MH, Engelhard VH, Thistlethwaite JR, Jr., Woodle ES.  Inhibition of T-cell activation by a monoclonal antibody reactive against the Alpha 3 domain of human MHC class I molecules. J Immunol. 153 (3):1054-67, 1994.
  7. Alegre M-L, Peterson LJ, Jeyarajah DR, Weiser M., Bluestone JA, Thistlethwaite JR. Severe combined immunodeficient mice engrafted with human splenocytes have functional human T cells and reject human allografts. J Immunol. 153 (6): 2738-49, 1994 Sept.
  8. Jeyarajah DR, Kadakia RA, O'Toole K, Newell KA, Josephson MA, Spargo BH, Woodle ES, Thistlethwaite JR, Jr. Changes in urinary cytokine mRNA profile after successful therapy for acute cellular renal allograft rejection.  Transplant Proc. 27 (1):887-9, 1995 Feb.
  9. Abbasoglu O, Levy MF, Brkic BB, Testa G, Jeyarajah DR, Goldstein RM, Husberg BS, Gonswa TA, Klintmalm GB. Ten years of liver transplantation: An evolving understanding of late graft loss.  Transplantation. 64 (12):1091-6, 1997.
  10. Jeyarajah DR, McBride M, Gonwa TA. Combined liver-kidney transplant: What are the indications? Transplantation. 66 (4):1091-6, 1997.
  11. Jeyarajah DR, Gonwa TA, McBride M, Testa G, Abbasoglu O, Husberg BS, Levy MF, Goldstein RM, Klintmalm GB.  Hepatorenal syndrome: Combined liver-kidney transplantation versus isolated liver transplant.  Transplantation. 64 (12): 1760-5, 1997.
  12. Jeyarajah DR, Gonwa TA, Testa G, Abbasoglu O, Goldstein R, Husberg BS, Levy M, Klintmalm GB. Liver and kidney transplantation for polycystic disease. Transplantation. 27; 66 (4):529-32, 1998 Aug.
  13. Prabhakar G, Testa G, Abasoglu O, Jeyarajah DR, Goldstein RM, Levy MF, Husberg BS, Gonwa TA, Klintmalm GB. The safety of cardiac surgery in the liver transplant patients. Ann Thorac Surg. 65 (4):1060-4, 1998.
  14. Jeyarajah DR, Netto GJ, Lee SP, Testa G, Abbasoglu O, Husberg BS, Levy MF, Goldstein RM, Gonwa TA, Tillery GW, Crippin JS, Klintmalm GB. Recurrent primary sclerosing cholangitis after orthotopic liver transplantation: is chronic rejection part of the disease process?  Transplantation. 66 (10):1300-6, 1998 Nov.
  15. Testa G, Goldstein RM, Toughanipour A, Abbasoglu O, Jeyarajah DR, Levy MF, Husberg BS, Gonwa TA, Klintmalm GB.  Guidelines for surgical procedures after liver transplantation. Am Surg. 227 (4) 590-9, 1998.
  16. Jeyarajah DR, Klintmalm GB. Is liver transplantation indicated for cholangiocarcinoma? J Hepatobiliary Pancreat Surg. 5 (1):48-51, 1998.
  17. Jeyarajah DR, Kielar M, Penfield J, Lu CY. Docosahexaenoic acid (DHA),
    component of fish oil, inhibits nitric oxide (NO) production in vitro. J Surg Res. 83 (2):147-50, 1999 May.
  18. Lu CY, Penfield ML, Kielar ML, Vasquez MA, Jeyarajah DR.  Hypothesis: Is renal allograft rejection initiated by a response to injury sustained during the transplant process? Kidney International. 55 (6):2157-68, 1999 Jun.
  19. Penfield JG, Dawidson IA, Ar'Rajab A, Kielar MA, Jeyarajah DR, Lu CY.   Syngeneic renal transplantation increases the number of renal dendritic cells in the rat. Transplant Immunology. (4):197-200, 1999 December 7.
  20. Penfield JG, Wang Y, Li S, Kielar MA, Sicher SC, Jeyarajah DR, Lu CY.  Transplant surgery injury recruits recipient MHC class II- positive leukocytes into the kidney. Kidney Int.. 56 (5):1759-69, 1999 November.
  21. Scott DJ, Bergen PC, Euhus DM, Guo W, Jeyarajah DR, Laycock R, Rege RV, Tesfay ST, Thompson WM, Valentine RJ, Jones DB. Intense laparoscopic skills training improves operative performance of surgery residents. Am College of Surgeons, Surgical Forum. 670-671, 1999.
  22. Meyer P, Nwariaku O, McClelland RN, Gibbons D, Leach F, Sagalowsky AL, Simmang CL, Jeyarajah DR. Rare presentation of Actinomycosis as an abdominal mass. Dis Colon and Rectum. 43:872-875, 2000 Jun.
  23. Kielar ML, Jeyarajah DR, Penfield JG, Lu CY. Docosahexaenoic acid decreases IRF-1 mRNA and thus inhibits activation of both the IRF-E and NF6d response elements of the iNOS promoter. Transplantation. 69 (10):2131-7, 2000 May 27.
  24. Scott DJ, Bergen PC, Rege RV, Laycock R, Tesfay ST, Valentine RJ, Euhus DM, Jeyarajah DR, Thompson WM, Jones DB. Laparoscopic training on bench models:  better and more cost effective than operating room experience? American College of Surgeons. 191(3):272-83, 2000 September.
  25. Kielar ML, Sicher SC, Penfield JG, Jeyarajah DR, Lu CY. Nitric Oxide inhibits IFN-g induced increases in CIITA mRNA abundance an activation of CIITA dependent genes - Class II MHC, Ii and H-2M. Inflammation. 24(5):431-45, 2000 October.
  26. Vazquez MA, Jeyarajah DR, Kielar ML, Lu CY. Long-term outcomes of renal transplantation: A result of the original endowment of the donor kidney and the inflammatory response to both alloantigens and injury.  Curr Opinion Nephrol and Hypertension. 9 (6):643-8, 2000 Nov.
  27. Jeyarajah DR. Localized Hepatocellular Carcinoma. Current Treat Options Gastroenterol. 3(6):463-472, 2000 Dec.
  28. Scott DJ, Young WN, Watumull LM, Lindberg G, Fleming JB, Huth JF, Rege RV, Jeyarajah DR, Jones DB. Accuracy and effectiveness of laparoscopic vs open hepatic radiofrequency ablation. Surgical Endoscopy. 15(2):135-40, 2001 Feb.
  29. Burdick JS, Garza AA, McGee DJ, Dykes C, Jeyarajah DR. Endoscopic management of afferent loop syndrome of malignant etiology. Gastrointestinal Endoscopy. 55(4): 602-5, 2002 Apr.
  30. Kielar M, Jeyarajah DR, Lu CY. The regulation of ischemic acute renal failure by extrarenal organs. Current Opinions in Nephrology and Hypertension. 11: 451-457, 2002.
  31. Kielar ML, Jeyarajah DR, Zhou XJ, Lu CY. Docosahexaenoic acid ameliorates murine ischemic acute renal failure and prevents increases in mRNA abundance for both TNF-a and inducible nitric oxide synthase. Journal of the American Society of Nephrology. 14(2): 389-396, 2003 Feb.
  32. Jeyarajah DR, Kielar ML, Lindberg G, Gokaslan ST, Lu CY. Hepatic IL10 and IL1RA response to bile duct ligation ameliorates pancreatitis.(In review)
  33. Jeyarajah DR, Kielar M, Gokaslan ST, Lindberg G, Lu CY. Fas deficiency exacerbates cerulein-induced pancreatitis. J of Investigative Surgery. 16(6): 325-333, 2003 Nov-Dec.
  34. Jeyarajah DR, Kielar ML, Frantz N, Lindberg G, Lu CY. Infection by gram-negative organisms via the biliary route results in greater mortality than portal venous infection. Clin Diagn Lab Immunol. 10(4):664-9, 2003 Jul.
  35. Zhang Y, Woodward VK, Shelton JM, Richardson JA, Zhon XJ, Link D, Kielar ML, Jeyarajah DR, Lu CY. Ischemia/reperfusion induces G-csf gene expression by renal medullary thick ascending limb cells in vivo and in vitro. AJP-Renal Physiology. 2004 June 286(6); F1193-201 Epub. 2004 Jan 20.
  36. Jeyarajah DR.  Recurrent Pyogenic Cholangitis.  Current Therapeutic Options in Gastroenterology. 7(2): 91-98, 2004 Apr.
  37. Jeyarajah DR, Kielar ML, Zhon XJ, Zhang Y, Lu CY.  Acute bile duct ligation ameliorates ischemic renal failure.  Nephron Physiology:  95(2): 28-35, 2003.
  38. Bell CL, Jeyarajah DR. Management of the cirrhotic patient that needs surgery.
    Curr Treat Options Gastroenterol. 8(6):473-80, 2005 Dec.
  39. Kielar ML, John R, Bennett M, Richardson JA, Shelton JM, Chen L, Jeyarajah DR, Zhou XJ, Zhou H, Chiquett B, Nagami GT, Lu CY.Maladaptive role of IL-6 in ischemic acute renal failure.
    J Am Soc Nephrol. 16(11):3315-25, 2005 Nov. Epub. 2005 Sep 28.
  40. Mayo M, Mosby J, Jeyarajah DR, Combes B, Khilnani S, Handem I, Grammer A, Lipsky P. The relationship between hepatic immunoglobulin production and CD154 expression in chronic liver diseases.
    Liver Int. 26(2):187-96, 2006 Mar.
  41. Bell CL, Yorgason J, Jessen, ME, Joseph S, Jain T, Jeyarajah DR. Management of hepatic and intracardiac echonicoccal cysts: case report and review of the literature. Surgical infection. (3): 309-13, 2006 Jun 7.
  42. Jeyarajah DR, Kielar ML, Saboorian M, Frantz NL, Lu CY.  Impact of bile duct obstruction on hepatic E. coli infection: role of IL-10.
    Am J Physiol Gastrointest Liver Physiol. 291(1):G91-4, 2006 Jul.
  43. Hamilton, L, Jeyarajah DR. Role of HgbA1c in predicting progression to diabetes after Whipple Procedure.  Journal of Hepatobiliary and Pancreatic Surgery. 9(6):461-65, 2007.
  44. Jeyarajah, DR. Minimally Invasive surgeries can remove tumors of the esophagus, liver, and pancreas. Dallas Medical Journal. 93(5), 2007 May.
  45. Rassadi, R, Jeyarajah, DR. Nodal sampling in periampullary cancer: does it change your approach? Journal of Hepatobiliary and Pancreatic Surgery. 9(6):461-5, 2007.
  46. Rassadi, R, Jolley, TM, Saad, J, Jeyarajah, DR, Tarnasky, P. An unusual case of annular pancreas arising from the dorsal duct. GI Endosc. 67(3):544-5, 2008 Mar.
  47. Sokolich, J, MD, Gonzalez, MV, MD, Jeyarajah, DR, MD, Rassadi, RR, MD, Dunn, E, MD.Hepatic echinoccocal cyst presenting as anaphylactic shock. DMJ. 94 (3), 2008 March.
  48. Moldrem A, Broker H, Papaconstantinou H, Megison S, Jeyarajah DR.  Late Presentation of Malrotation: An Argument for Elective Repair. World J Surg. 32(7):1426-31, 2008 Jul.
  49. Rassadi, R, Dickerman, RM, Dunn, EL, Mejia, A, Tarnasky, P, Linder, JD, Cheng, S, Jeyarajah, DR. HPB surgery: what is the right fellowship for the right training? Journal of Surgical Education. 65(3):186-90, 2008 May-June.
  50. Khithani, A, Curtis, D, Galanopoulos, C, Jeyarajah, DR. Pancreaticoduodencteomy after roux en y gastric bypass. J Obes Surg. 19(6):802-5, 2009.
  51. Sokolich, J, Galanopoulos, C, Dunn E, Linder, JD, Jeyarajah, DR. Expanding the indications for laparoscopic gastric resection for GIST: size is not a limitation. JSLS. 13(2):165-9, 2009 Apr-Jun.
  52. Hankins, D, Chao, S, Dolmatch, B, Jeyarajah, DR. Covered stents for late post-operative arterial hemorrhage after pancreaticoduodenectomy.  JVIR. 20(3); 407-9, 2009 Mar.
  53. Khithani A, Curtis, D, Dickerman R, Jeyarajah, DR. Extended drainage of the pancreatic duct after Pancreaticoduodenectomy. Archives of Surgery. 144(12) 1163-6, 2009 Dec.
  54. Tarnasky, PR, MD, Linder, JL, MD, Mejia, A, MD, Dickerman, RD, MD, Jeyarajah, DR, MD, Cheng, S, MD. Bile duct obstruction after cholecystectomy due to clips: undo what has been undone, then do what you normally do. Gastrointest Endosc. 69(4):19-21, 2009 Apr.
  55. Khithani A, Curtis D, Galanopoulos, C, Vo A, D. Jeyarajah, DR: Zero Leaks with  Minimal Invasive Esophagectomy: a team-based approach. JSLS. 13(4):542-9, 2009 Oct-Dec.
  56. Jeyarajah, DR , Christos Galanopolos, Amit Khithani. The Whipstow Procedure: An Innovation modification to the whipple procedure. American Surgeon. 76(1) 71-2, 2010.
  57. Christian, DJ, Khithani, A, Castro-Arreola, M, Jeyarajah, DR. Surgical Management of Gastric Varices and Morbid Obesity: A Novel Approach. Surg Obes Relat Dis. 6(4):448-450, 2010. 
  58. Chahal, P, Saad, AJ, Jeyarajah DR. An Unusual Case of Coexeistent Serous Cystadenoma and Intraductal Papillary Mucinous neoplasm of the Pancreas: EUS to the Rescue! JOP. 12 (3):244-6, 2011 May 6.
  59. Christian, DJ, Khithani, A, Jeyarajah, DR. Making liver transection even safer- a novel use of microwave technology. Am Surg. 77(4); 417-21, 2011 Apr.
  60. Khithani, A, Vo, A, Tarnasky, P, Linder, Jeyarajah, DR. Feasibility of Pancreaticoduodenectomy in a non university tertiary care center (NUTCC): What are the key elements of success? Am Surg. 77(5); 545-51, 2011 May.
  61. Lowe K, Jeyarajah DR (2011) Integration of Surgery and Radioembolization in Treatment of Hepatic Tumors. J Nucl Med Radiat Ther 2:105.
  62. Kevin Lowe, Amit Khithani, Alejandro Mejia, Stephen Cheng, D. Rohan Jeyarajah. All lymph node positive patients are not equal: a new paradigm in gallbladder cancer. Am Surg. 78 (1): 147-8, January 2012.
  63. Jeyarajah, DR. No They Don't: Would You Let That 5-Year Grad Do Your Whipple? Let My Fellow Do 50-Whipples, and He Will Provide Better Outcomes. (In Press).
  64. Lowe, K., Khithani, A., Liu, E., Winston, T., Christian, D., Saad, J. and Jeyarajah, D. R. (2012), Ki-67 labeling: A more sensitive indicator of malignant phenotype than mitotic count or tumor size?. J. Surg. Oncol., 106: 724–727.
  65. Jeyarajah, DR, Khithani, A, Siripurapu, V, Liu, E, Thomas, A, Saad, AJ. Lymph node retrieval in pancreaticoduodenectomy specimens: does educating the pathologist matter? HPB, 2013 May 15 (E Pub)
  66. Osman, H, Siripurapu, V, Thomas, A, Liu, E, Winston, T, Jeyarajah, DR. A Surgeon's Story: A Continued Progression in Pancreaticoduodenectomies after a Decade Long Experience. HPB. (In Review).
  67. Osman, H, Siripurapu V, Thomas, A, Liu, E, Jeyarajah, DR. Why reconstruct the Superior Mesenteric Vein in resectable pancreatic cancer when the Superior Mesenteric Artery margin is positive? HPB. (In Review).
  68. Osman, H, Liu, E, Thomas, A, Winston, T, Jeyarajah, DR. Quicker return of bowel function with Alvimopan in patients undergoing Pancreaticoduodenectomy. Surgical Innovation. (In Review).

Abstracts

  1. Smith DM, Jeyarajah DR, Hussain S, Woodle ES, Thistlethwaite JR, Jr., Bluestone JA.  Human T-lymphocyte activation in response to anti-CD3 monoclonal antibody, alloantigen or xenoantigen is inhibited by a monoclonal anti-HLA class I antibody.  Joint meeting of the American Association of Immunologists [AAI] and the Clinical Immunology Society [CIS], Denver, Colorado.
  2. Alegre M-L, Peterson LP, Jeyarajah DR, Kowalkowski K, Bluestone JA, Thistlethwaite JR, Jr. Immunomodulatory properties OKT3 in a model of SCID mice reconstituted with human splenocytes: prolongation of graft survival.  Autoimmunology Conference, Chicago. May 1992.
  3. Jeyarajah DR, Kielar M, Penfield J, Lu CY.  Docohahexaenoic acid (DHA), a component of fish oil, inhibits nitric oxide (NO) production in vitro. Association of Academic Surgeons: 32nd Annual Meeting, Seattle, WA. November 1998. (Oral presentation).
  4. Scott DJ, Valentine RJ, Bergen PC, Jeyarajah DR, et al. Intense laparoscopic skills training improves operative performance.  American College of Surgeons. October 1999.
  5. Bieligk SC, Huang H, Fleming JB, Anthony T, Jones DB, Jeyarajah DR, DeMaio M, Beitsch P, Huth JB, Rege RV.  The utility of laparoscopy in the staging evaluation and management of upper gastrointestinal malignancies. American College of Surgeons - North Texas Chapter. February 2000.
  6. Scott DJ, Young WN, Watumull LM, Lindberg GM, Fleming JB, Huth JF, Rege RV, Jeyarajah DR, Jones DB.  Intraoperative ultrasound assessment of hepatic radio frequency ablation. (Presentation). SSAT, San Diego, CA. May 22, 2000.
  7. Kielar ML, Jeyarajah DR, Reed D, Wright BJ, Lu CY.  The liver regulates renal ischemic injury: a possible role for renal IL6 and hepatic IL10?  UT Southwestern Medical Center, Dallas, TX.  Journal of the American Society of Nephrology.2000.
  8. Kielar ML, Jeyarajah DR, Reed D, Wright BJ, Lu CY.  The abundance of mRNA for the transcription factor [interferon response factor 1 (IRF-1)] increases after renal ischemia reperfusion injury: transgenic knockout (KO) of IRF-1 ameliorates injury.  Journal of the American Society of Nephrology.2000.
  9. Kielar ML, Jeyarajah DR, Reed D, Wright BJ, Lu CY.  A role for Interleukin 6 (IL6) in ischemic acute renal failure: the abundance of IL6 mRNA increases the kidney after ischemia-reperfusion injury, and transgenic knockout of IL6 exacerbates murine ischemic acute renal failure. Journal of the American Society of Nephrology.  2000.
  10. Jeyarajah DR, Kielar M, Lindberg G, Gokaslan ST, Lu CY.  Hepatic IL 10, produced in response to bile duct ligation (BDL), ameliorates acute pancreatitis.  Oral presentation Third Biennial Americas Hepatopancreatobiliary Congress, Miami Beach, FL, February 2001. 
  11. Jeyarajah DR, Kielar M, Lindberg G, Gokaslan ST, Lu CY.  FAS Ameliorates Cerulein-Induced Pancreatitis (AP).  Poster presentation Third Biennial Americas Hepatopancreatobiliary Congress, Miami Beach, FL, February 2001.
  12. Zhang Y, Woodward VK, Kielar ML, Jeyarajah DR, Sorrells AC, Dunn JS: G-CSF Protein and mRNA Abundance Is Increased in the Murine Kidney aster Ischemia Reperfusion In Vivo and in Renal Tubular Cells (mTAL) after Exposure to Reactive Oxygen Species (ROS) in Vitro. Journal of the American Society of Nephrology, 12:796, September 2001.
  13. Kielar ML, Jeyarajah DR, Dunn JS, Lu CY: IRF-1 Antisense Treatment Ameliorates Renal Ischemia Reperfusion Injury. Journal of the American Society of Nephrology, 12:784, September 2001.
  14. Jeyarajah DR, Kielar M, Lu CY.  Major differences in mortality after biliary versus venous (portal or systemic) routes of gram-negative infection in a novel murine model. (Oral presentation). SIS/SIS-E Joint Meeting, Madrid, Spain, May 2002.
  15. Jeyarajah DR, Kielar ML, Frantz N, Zhang Y, Woodward V, Lu CY.  Acute bile duct ligation impairs hepatic clearance of bacteria by induction of maladaptive cytokines.  (Poster presentation). AAS 36th Annual Meeting. Boston MA. Nov 2002.
  16. Jeyarajah DR, Kielar M, Frantz N, Lu CY. Interleukin 10, produced in response to biliary obstruction and hepatic infection, is protective. J Surg Res. 114(2):290, Oct 2003.
  17. Jeyarajah DR, Kielar M, Frantz N, Lu CY. Interleukin 10, produced in response to biliary obstruction and hepatic infection, is protective.  (Poster presentation). AAS 37th Annual Meeting. Sacramento, CA. 2003.
  18. Jeyarajah DR, Kielar ML, Zhon X, Frantz NL, Karimi P, John R, Lu CY.  A Role Model of Cholangitis Results in neutropinel recruitment by MIP2.  (Poster presentation).  Surgical Infection Society.  Indianapolis, IN. April 2004.
  19. Jeyarajah DR, Kielar ML, Frantz NL, Karimi P, John R, Lu CY.  Role of TLR 4 in Cholangitis. (Oral presentation). 6th World Congress AHPBA.  Washington DC. June 2004.
  20. Broker H, Waltrip A, Megison S, Gregorcyk SG, Simmang CL, Huber P, Papaconstantinou H, Jeyarajah DR.  Late Presentation of Malrotation: An Argument for Elective Repair.  J Surg Res. 2004; 121:318.The Association for Academic Surgery 38th Annual Meeting, Houston, TX. November 2004.
  21. Jeyarajah DR, Kielar ML, Zhou X, Karimi P, Frantz NL, Lu CY.  Role of Neutrophils and Kupffer Cells in Hepatic Cells in Hepatic Infection: Do We Have it Wrong?  The Association for Academic Surgery 38th Annual Meeting, Houston, TX. November 2004.
  22. Hamilton L, Papaconstantinou P, Naylor RA, Tchorz K, Bergen P, Purdue G, Jeyarajah DR.  Change in Students' Perspectives of Surgeons as they progress through Medical School American College of Surgeons meeting. Oct 2005.
  23. Rassadi, R, Vo, A, Jeyarajah DR. Feasibility of pancreaticoduodenectomy (the whipple procedure) in a high volume community center. AHBPA Las Vagas. April 2007.
  24. Rassadi, R, Jeyarajah, DR. Nodal sampling in periampullary cancer: does it change your approach? AHBPA Las Vagas. April 2007.
  25. Rassadi, R, Dickerman, RM, Dunn, EL, Jeyarajah, DR. Liver, pancreas, and biliary surgery, what is the right fellowship for the right training? AHBPA Las Vagas. April 2007.
  26. Roozbeh Rassadi, Jeyarajah, DR. Sentinel Lymph Node Sampling: Is It Meaningful in Pancreaticodudenectomy? SSAT Washington DC. June 2007.
  27. Christos A. Galanopoulos, Allison Vo, Jeyarajah, DR. A Novel use of the Harmonic ACE during pancreaticoduodenectomy with no post-operative bleeding. AHPBA, Ft Lauderdale. March 2008.
  28. Christos A Galanopoulos, Jeyarajah, DR, MD. The Whipstow Procedure: An Innovation modification to the whipple procedure. AHPBA, Ft Lauderdale. March 2008.
  29. Christos A. Galanopoulos, Allison Vo, Jeyarajah, DR. Year 2: An update of a high Volume Non university Referral center pancreaticoduodenectomy feasability study. AHPBA, Ft Lauderdale. March 2008.
  30. Christos A. Galanopoulos, Gong A. Lee, Girish P. Joshi, Jeyarajah, MD. A Novel use of On Q pain pumps during pancreaticoduodenectomy: Celiac ganglia placement.
  31. Julio Sokolich, Christos A. Galanopoulos, Allison Vo, Maggie White, Ernest Dunn, Jeyarajah, DR. Development of a Dedicated Team Decreases ICU Admission After pancreaticoduodenectomy. SSAT San Diego. May 2008.
  32. Amit Khithani, Christos Galanopoulos, Allison Vo, John Jay, D. Rohan Jeyarajah. Safety of Minimally Invasive Esophagectomy: ISGIO, Washington DC. Sept 2008.
  33. David Curtis M.D, Amit Khithani MBBS, Maggie White RN, D. Rohan Jeyarajah MD. No ICU post pancreaticoduodenectomy: A reality, even with debilitated patients. SSO, Phoenix AZ. March 2009.
  34. David Curtis MD, Amit Khithani MBBS, Allison Vo RN, D. Rohan Jeyarajah MD.  Pancreaticoduodenectomy (PD) at a non university tertiary care center (NUTCC).Outcomes and feasibility. SSO, Phoenix AZ. March 2009.
  35. David Curtis MD, Amit Khithani MBBS, John Jay MD, Allison Vo RN, D. Rohan Jeyarajah MD. Feasibility of performing minimally invasive esophagectomy (MIE) at a non university tertiary training center (NUTTC). SSO, Phoenix AZ. March 2009.
  36. Amit S Khithani, MBBS, David E Curtis, MD, Maggie White, RN, D. Rohan Jeyarajah, MD. Reducing ICU admissions in higher ASA class patients after pancreaticoduodenectomy: Impact of a team based approach. AHBPA, Miami Beach. April 2009.
  37. David Curtis, MD, Amit Khithani, MBBS, A. Joe Saad, MD, D. Rohan Jeyarajah, MD. Margin status with a standardized protocol for the sectioning of pancreaticoduodenectomy specimens. AHBPA, Miami Beach. April 2009.
  38. Khithani, MBBS, David Curtis, MD, A. Joe Saad, MD, Jeffrey D. Linder, MD, Paul Tarnasky MD, D. Rohan Jeyarajah, MD. Malignant potential in Intraductal Papillary Mucinous Neoplasm (IPMN): Why observe?Amit AHBPA, Miami Beach. April 2009.
  39. David Curtis, MD, Amit Khithani, MBBS, Kesha Henderson MD, Alejandro Mejia MD, Stephen Cheng MD, D. Rohan Jeyarajah, MD. Gallbladder cancer- still a bad disease. AHBPA, Miami Beach. April 2009.
  40. David Curtis, MD, Amit Khithani, MBBS, MD, D. Rohan Jeyarajah, MD. Gallbladder cancer found after laparoscopic cholecystectomy: Is port site excision necessary? DDW. May 2009.
  41. Amit Khithani, MBBS, David E Curtis, MD, Christos Galanopoulos MD , John Jay MD, D. Rohan Jeyarajah, MD. Minimally invasive esophagectomies (MIE) at a non university tertiary care center (NUTTC): Feasibility and outcomes. DDW. May 2009.
  42. Amit S Khithani, MBBS, David E Curtis, MD, Christos Galanopoulos MD, D. Rohan Jeyarajah, MD. Pancreaticoduodenectomy (PD) at a non university tertiary care center (NUTCC): Outcomes and feasibility. DDW. May 2009.
  43. Amit S Khithani, MBBS, David E Curtis, MD, A. Joe Saad, MD, D. Rohan Jeyarajah, MD. An aggressive approach to pancreaticoduodenectomy (PD)-Surgeon's clinical suspicion matters. DDW. May 2009.
  44. Siripurapu, V, Liu, E, Khithani, A, Jeyarajah, DR. Pancreaticoduodenectomies in High Volume Centers; Direct transfer to floor improves Length of Stay without affecting morbidity or mortality. (Poster Presentation) SSO. March 2012.
  45. Siripurapu, V, Liu, E, Khithani, A, Jeyarajah, DR. Tumor Location in Pancreatic Cancer Does Not Affect Lymph Node Ratio Despite Significant Difference in Lympho-vascular Invasion. SSO. March 2012.
  46. Siripurapu, V, Liu, E, Winston, T, Jeyarajah, DR. Pancreaticoduodenectomies in High Volume Centers; Direct transfer to floor improves Length of Stay without affecting morbidity or mortality. (Poster Presentation) North Texas Chapter-ACS. February 2012.
  47. Siripurapu, V, Liu, E, Khithani, A, Mejia, A, Dickerman, R, Jeyarajah, DR. Tumor Location in Pancreatic Cancer Influences Lymph Node Positivity. (Oral Poster Presentation) AHPBA. March 2012.
  48. Siripurapu, V, Liu, E, Khithani, A, Mejia, A, Dickerman, R, Jeyarajah, DR. Tumor Location in Pancreatic Cancer Influences Lymph Node Positivity. (Oral Presentation) North Texas Chapter-ACS. February 2012.
  49. Siripurapu, V, Liu, E, Khithani, A, Winston, T, R, Jeyarajah, DR. Superior Mesenteric Vein (SMV) Margin Positivity in Resectable Pancreatic Cancer Correlates with High Superior Mesenteric Artery (SMA) Margin Positivity; Is Vein Resection Advisable? (Oral Poster Presentation) AHPBA. March 2012.
  50. Siripurapu, V, Liu, E, Khithani, A, Winston, T, R, Jeyarajah, DR. Superior Mesenteric Vein (SMV) Margin Positivity in Resectable Pancreatic Cancer Correlates with High Superior Mesenteric Artery (SMA) Margin Positivity; Is Vein Resection Advisable? (Oral Presentation) North Texas Chapter-ACS. February 2012.
  51. Siripurapu, V, Winston, T, Liu, E, Jeyarajah, DR. Referral Patterns in Pancreatic Cancer to a High Volume Center; The Gastroenterologist Remains Your Friend. (Oral Poster Presentation) AHPBA. March 2012.
  52. Siripurapu, V, Winston, T, Liu, E, Jeyarajah, DR. Referral Patterns in Pancreatic Cancer to a High Volume Center; The Gastroenterologist Remains Your Friend. (Poster Presentation) North Texas Chapter-ACS. February 2012.
  53. Siripurapu, V, Liu, E, Khithani, A, Winston, T, Jeyarajah, DR. A Surgeon's Learning Experience of Pancreaticoduodenectomies (PD): It Continues Despite a Decade Long Experience. (Oral Poster Presentation) AHPBA. March 2012.
  54. Siripurapu, V, Liu, E, Khithani, A, Winston, T, Jeyarajah, DR. A Surgeon's Learning Experience of Pancreaticoduodenectomies (PD): It Continues Despite a Decade Long Experience. (Mini Talk) North Texas Chapter-ACS. February 2012.
  55. Siripurapu, V, Mekala, A, Liu, E, Jeyarajah, DR. Preoperative Chemotherapy in High Risk Gastric Cancer. No Guarantee of Downstaging but remains our best MAGIC bullet. (Oral Presentation) North Texas Chapter-ACS. February 2012.
  56. Liu, E, Siripurapu, V, Winston, T, Jeyarajah, DR. Alvimopan Patients Show Significant Improvement in Recovery Post Pancreaticoduodenectomy Surgeries. (Poster Presentation) DDW-SSAT. May 2012.
  57. Osman, H, Liu, E, Siripurapu, V, Winston, T, Jeyarajah, DR. Alvimopan Patients Show Significant Improvement in Recovery Post Pancreaticoduodenectomy Surgeries. (Poster Presentation) North Texas Chapter -ACS. February 2013.
  58. Winston, T, Siripurapu, V, Liu, E, Jeyarajah, DR. Hepatic Fibrosis Due to Biliary Obstruction is Under Apprecieated at the Time of Pancreaticoduodenectomy: A Word of Caution. (Poster Presentation) IHPBA. July 2012.
  59. Osman, H, Thomas, A, Jeyarajah, DR. The Need for Jejunal Feed or TPN After Pancreaticoduodenectomy (PD): Is It Predictable? (Oral Poster Presentation) AHPBA. February 2013.
  60. Osman, H, Thomas, A, Jeyarajah, DR. The Need for Jejunal Feed or TPN After Pancreaticoduodenectomy (PD): Is It Predictable? (Poster Presentation) North Texas Chapter-ACS. February 2013.
  61. Osman, H, Thomas, A, Jeyarajah, DR. Not All Nodes Are the Same: Nodal Stations Variability in Pancreaticoduodenectomy (PD) and Role In Decision Making. (Oral Poster Presentation) AHPBA. February 2013.
  62. Osman, H, Thomas, A, Jeyarajah, DR. Not All Nodes Are the Same: Nodal Stations Variability in Pancreaticoduodenectomy (PD) and Role In Decision Making. (Oral Scientific Presentation) North Texas Chapter-ACS. February 2013.
  63. Osman, H, Thomas, A, Jeyarajah, DR. Intraoperative Estimated Blood Loss Predicts Need for ICU Care: A Single Center Experience. (Oral Poster Presentation) AHPBA. February 2013.
  64. Osman, H, Thomas, A, Jeyarajah, DR. Intraoperative Estimated Blood Loss Predicts Need for ICU Care: A Single Center Experience. (Poster Presentation) North Texas Chapter-ACS. February 2013.
  65. Osman, H, Thomas, A, Jeyarajah, DR. Body Mass Index (BMI): Does It Make a Difference in Pancreaticoduodenectomy Outcome? (Oral Poster Presentation) AHPBA. February 2013.
  66. Osman, H, Thomas, A, Jeyarajah, DR. Body Mass Index (BMI): Does It Make a Difference in Pancreaticoduodenectomy Outcome? (Oral Scientific Presentation) North Texas Chapter-ACS. February 2013.
  67. Osman, H, Rice, M, Winston, T, Thomas, A, Jeyarajah, DR. Preoperative Chemotherapy Results in Unpredictable Response in Gastric Cancer: No Magic Bullet. (Mini Talk) North Texas Chapter-ACS. February 2013.
  68. Osman, H, Rice, M, Winston, T, Thomas, A, Jeyarajah, DR. Preoperative Chemotherapy Results in Unpredictable Response in Gastric Cancer: No Magic Bullet. (Poster Presentation) DDW-SSAT. May 2013.
  69. Osman, H, Winston, T, Thomas, A, Majid, A, Shahin, I, Van Meter, T, Jeyarajah, DR. Selective Internal Radiation Therapy (SIRT) Using Yttrium-90 in Atypical Liver Tumors; Single Center Experience. (Oral Scientific Presentation) North Texas Chapter-ACS. February 2013
  70. Osman, H, Jeyarajah, DR. Hepato-Pancreato-Biliary (HPB) Surgery Fellows: What is After Fellowship? A Single Fellowship Experience (Oral Poster Presentation) AHPBA. February 2013.
  71. Osman, H, Parikh, J, Patel, S, Jeyarajah, DR. Are general surgery residents adequately prepared for hepatopancreaticobiliary (hpb) fellowships? Questionnaire based study (Oral Poster Presentation) AHPBA 2014.
  72. Cheek, S, Patel, S, Osman, H, Jeyarajah, DR. The benefits of laparoscopic pancreatectomy: it does make a difference (Oral Poster Presentation) AHPBA 2014.
  73. Cheek, S, Patel, S, Osman, H, Jeyarajah, DR. Differences in outcomes in pancreaticoduodenectomy (PD) in the modern era: does a malignant diagnosis make a difference? (Oral Poster Presentation) AHPBA 2014.
  74. Cheek, S, Patel, S, Osman, H, Jeyarajah, DR. Concept of the mesopancreas: coining a new surgical anatomical space (Oral Poster Presentation) AHPBA 2014.
  75. Patel, S, Cheek, S, Winston, T, Osman, H, Jeyarajah, DR. Is there a "July effect" for HPB cases? (Oral Poster Presentation) AHPBA 2014.
  76. Patel, S, Cheek, S, Winston, T, Osman, H, Jeyarajah, DR. Incidental gallbladder cancer on cholecystectomy: is there more than meets the eye? (Oral Poster Presentation) AHPBA 2014.
  77. Osman, H, Jeyarajah, DR. The current state of HPB fellowship experience in North America (Oral Poster Presentation) AHPBA 2014.

LECTURES

  1. Texas Medical Association Meeting: Current Status of Portal Hypertension. May 1999.  Dallas, Texas.
  2. Current Topics in General Surgery: Surgical Management of Portal Hypertension. May 1999. Dallas, Texas.
  3. Laparoscopic Splenectomy Course for SCMIS: Surgical Indications for Splenectomy. May 1999. Dallas, Texas.
  4. Surgical Grand Rounds: Liver: Center of the Soul or Just Another Organ.  June 1999.  Dallas, Texas.
  5. Multicultural Awareness Week: I'm Just a Country Doc. Question is, From What Country? April 2000. Dallas, Texas.
  6. Science of Family Medicine: Acalculus Gallbladder Disease. June 2000. Dallas, Texas.
  7. Surgical Grand Rounds Methodist Hospital:  Surgical Management of Liver Disease. April 2002. Dallas, Texas.
  8. Surgical Research Forum: Timing of Bile Duct Ligation Impacts Clearance of Portal Venous Pathogen. June 2003. Dallas, Texas.
  9. Current Topics in General Surgery: Management of Misadventures in Laparoscopic Cholecystectomy.  May 2003.  Dallas, Texas.
  10. Current Topics in General Surgery: Diagnosis & Management of Liver Masses.  May 2004.  Dallas, Texas.
  11. Surgical Grand Rounds: Diagnosis and Management of Liver Masses.  Sept. 2004.  Dallas, Texas. 
  12. Greater General Surgery Grand Rounds – University of Chicago: Diagnosis and Management of Liver Masses. Jan 2005. Chicago, Illinois.
  13. Current Topics in General Surgery: Current Rx Options in Complicated Pancreatitis.  April 2005.  Dallas, Texas.
  14. Grand Rounds, Methodist Dallas Medical Center Sept 2005: Liver Masses- diagnosis and treatment.
  15. American College of surgeons April 2006. Follow up of patients with neuroendocrine tumors. Dallas, TX.
  16. Grand Rounds, Methodist Dallas Medical Center Sept 2006: What's new in pancreatic cancer.
  17. Pancreatic Cancer CME Course: Surgical treatment of pancreatic cancer. Feb 2007, Wichita Falls, TX.
  18. Regionalization of care for complex surgery: not so fast. SSAT Washington DC. May 2007.
  19. Pancreatic cancer- an update: Grand Rounds, Methodist Dallas Medical Center. Nov 2007.
  20. What's new in upper GI cancer: Surgery Grand rounds, Trinity Mother Frances Hospitals and Clinics - Tyler, Texas. Jan 2008.
  21. ICU care of the esophagectomy and Whipple pt: Nursing Dept Methodist Dallas Medical Center. Sept 2008.
  22. Update in pancreatic disease: North Texas Society of Pathologists. October 2008.
  23. Management of liver tumors. Liver Meeting Dallas. 2010.
  24. Contemporary Management of Liver Tumors- Satellite Symposium IHPBA. 2010.
  25. Management of CRC Metastases- Grand Rounds Methodist Dallas. May 2010.
  26. Grand Rounds University of Arkansas Medical Center 2010. "Cholangiocarcinoma"
  27. Debate DDW 2011; No they don't: Would you let that 5-year grad do your Whipple? Let my fellow do 50 Whipples, and he will provide better outcomes.
  28. Update on HPB disease: "Chemotherapy for pancreatic cancer". Meridian Health, NJ. November 2011.
  29. Grand Rounds Texas tech, Lubbock TX: "Diagnosis and Management of Liver Masses". February 2013
  30. AHPBA Ultrasound course: "Pancreatic Ultrasound". March 2013.
  31. Akron general Hospital Cancer Symposium: " Management of metastatic colorectal, breast, and melanoma to the liver". October 2013
  32. SSO / HPB Fellow's course leader - November 2012 and 13. Cincinnati, OH.

PRESENTATIONS

  1. Jeyarajah, DR, Schmeisser FS, Thistlethwaite JR, Jr.  Low-dose anti-CD3 therapy provides long term graft survival in a Lewis rat to C57BL/6 xeno-islet transplantation model.  International Congress of Pancreatic and Islet Transplantation, The Netherlands, June 1993.
  2. Jeyarajah DR, Schmeisser FS, Thistlethwaite JR, Jr.  Prolongation of xenograft survival with concomitant donor bone marrow transplantation.  Second International Congress on Xenotransplantation, Cambridge, England, September 1993.
  3. Jeyarajah DR, Kadakia RA, O'Toole K, Newell KA, Josephson MA, Spargo BH, Woodle ES, Thistlethwaite JR, Jr.  Changes in urinary cytokine mRNA after successful therapy for acute cellular renal allograft rejection. International Congress of Transplantation, Kyoto, Japan, Nov 1994.
  4. Abbasoglu O, Levy MF, Brkic B, Testa G, Jeyarajah DR, Goldstein RM, Husberg BS, Gonwa TA, Klintmalm GB.  Ten years of liver transplantation: An evolving understanding of late graft loss. American Society of Transplant Physicians: 16th Annual Meeting, Chicago, IL, May 1997.
  5. Jeyarajah DR, Gonwa TA, McBride M, Abbasoglu O, Goldstein RM, Husberg BS, Levy MF, Testa G, Klintmalm GB.  Does preoperative creatinine (Scr) affect outcome after orthotopic liver transplantation (OLTexas)?  American Society of Transplant Physicians: 16th Annual Meeting, Chicago, IL, May 1997.
  6. Testa G, Crippin J, Abbasoglu O, Goldstein RM, Husberg BS, Jeyarajah DR, Levy MF, Klintmalm GB.  Does recurrent autoimmune hepatitis after liver transplant have an impact on patient and graft survival? American Society of Transplant Physicians: 16th Annual Meeting, Chicago, IL, May 1997.
  7. Jeyarajah DR, Netto GJ, Lee SP, Testa G, Abbasoglu O, Husberg BS, Levy MF, Goldstein RM, Gonwa TA, Tillery GW, Crippin JS, Klintmalm GB.  Recurrent primary sclerosing cholangitis following orthotopic liver transplantation: Is chronic rejection part of the disease process?  International Liver Transplant Society: 5th Annual Meeting, Seattle, WA, October 1997.
  8. Jeyarajah DR, Kielar M, Penfield J, Lu CY.  Docosahexaenoic acid (DHA), a component of fish oil, inhibits nitric oxide (NO) production in vitro.  Association of Academic Surgeons: 32nd Annual Meeting, Seattle, WA, November 1998.
  9. Jeyarajah DR, Kielar ML, Devraj S.  A component of fish oil ameliorates renal ischemic injury.  Oral presentation International Surgery Week [ISW99], Vienna, Austria, August 1999.
  10. Jeyarajah DR, Kielar ML, Lu CY.  Bile Duct Ligation increases IL-10 production and protection in mice.  Oral presentation International Surgery Week [ISW99], Vienna, Austria, August 1999.
  11. Scott DJ, Bergen PC, Euhus DM, Guo WA, Jeyarajah DR, Laycock R, Rege RV, Tesfay ST, Thompson WM, Valentine RJ, Jones DB.  Comparison of Edited Videotape to Direct Observation to Assess Operative Performance after Laparoscopic Skills Training. Association for Academic Surgery, October 1999.
  12. Scott DJ, Bergen PC, Euhus DM, Guo WA, Jeyarajah DR, Laycock R, Rege RV, Tesfay ST, Thompson WM, Valentine RJ, Jones DB.  Evaluating Surgical Competency Using Absite, Skill Testing, and Intra-operative Assessment. Accepted for Central Surgical Association.
  13. Scott DJ, Young WN, Watumull LM, Lindberg GM, Fleming JB, Huth JF, Rege RV, Jeyarajah DR, Jones DB. Accuracy and effectiveness of laparoscopic versus open hepatic radio frequency ablation. Presentation. SAGES, March 29, 2000.
  14. Jeyarajah DR, Kielar M, Lindberg G, Gokaslan ST, Lu CY.  Hepatic IL 10, Produced in Response to Bile Duct Ligation (BDL), Ameliorates Acute Pancreatitis. Third Biennial Americas Hepatopancreatobiliary Congress, Miami Beach, FL, February 2001.
  15. Jeyarajah DR, Kielar M, Lu CY.  Major differences in mortality after biliary versus venous (portal or systemic) routes of gram-negative infection in a novel murine model.  SIS/SIS-E Joint Meeting, Madrid, Spain, May 2002.
  16. Jeyarajah DR. Management of misadventures in laparoscopic cholecystectomy. Current Topics in Gen. Surgery. Dallas, TX, May 2003.
  17. Jeyarajah DR. Current management of portal hypertension. 5th Annual Research Forum. Dallas, Texas, June 2003.
  18. Jeyarajah DR, Kielar ML, Saboorian M, Frantz NL, Lu CY.  Impact of Bile Duct Obstruction as Hepatic E-coli Infection.
  19. Jeyarajah DR, Kielar ML, Zhon X, Frantz NL, Karimi P, John R, Lu CY.  Role of TLR4 in Cholangitis.  Oral presentation at America Hepatobiliary Association.  Washington, DC, June 2004.
  20. Hamilton L, Papaconstantinou P, Naylor RA, Tchorz K, Bergen P, Purdue G, Jeyarajah DR.  Change in Students' Perspectives of Surgeons as they progress through Medical School. Oral presentation American College of Surgeons Meeting, Oct 2005.
  21. Rassadi R, Vo A, Jeyarajah DR. Feasibility and safety of Pancreaticoduodenectomy (the whipple procedure) in a non-university based referral center. Oral presentation North Texas Chapter American of College of Surgeons Meeting, Dallas, TX, Feb 2007.
  22. Rassadi R, Jeyarajah DR. Nodal Sampling in Periampullary Cancer: Does it change your approach? Oral presentation North Texas Chapter American of College of Surgeons Meeting, Dallas, TX, Feb 2007.
  23. Christos a. Galanopoulos, D. Rohan Jeyarajah: Laparoscopic Extended Distal Pancreatectomy for Tumors of the Pancreatic Neck. SSAT Meeting. San Diego, CA, May 2008.
  24. Amit Khithani, Christos Galanopoulos, Allison Vo, John Jay, D. Rohan Jeyarajah. Safety of Minimally Invasive Esophagectomy: ISGIO, Washington DC, Sept 2008.
  25. Amit Khithani, David Curtis, Allison Vo, John Jay, D. Rohan Jeyarajah: Safety of Minimally Invasive Esophagectomy in Malignancy. ACS North Texas Chapter.  Dallas, Texas, Feb 2009.
  26. David Curtis, Amit Khithani, D. Rohan Jeyarajah. Pancreaticoduodenectomy in the gastric bypass era. A new technique that works. ACS North Texas Chapter Dallas, Texas, Feb 2009.
  27. Safety of Minimally Invasive Esophagectomy (MIE) After Neoadjuvant Chemoradiotherapy and as Primary Resection at a Non- University Tertiary Care Center (NUTCC).  ISGIO, Philadelphia, October 2009.
  28. Amit Khithani, MBBS; Derick Christian, Joshua Barton, MD; John Jay, MD; D. Rohan Jeyarajah, MD. ONCOLOGIC EFFICACY OF MINIMALLY INVASIVE ESOPHAGECTOMY (MIE) AFTER NEOADJUVANT CHEMORADIOTHERAPY (NT) IN ESOPHAGEAL CANCER: Oral presentation North Texas Chapter American of College of Surgeons Meeting, Dallas, TX, Feb 2010.
  29. Derick Christian, Amit Khithani, MBBS; Joshua Barton, MD; D. Rohan Jeyarajah, MD. LIVER TRANSECTION WITH MICROWAVE TECHNOLOGY: A NOVEL TECHNIQUE. Oral presentation North Texas Chapter American of College of Surgeons Meeting, Dallas, TX, Feb 2010.
  30. Amit Khithani, MBBS; Joshua Barton, MD; D. Rohan Jeyarajah, MD. COUNSELING WITH THE PATHOLOGIST: IMPACTING NODE RETRIEVAL IN PANCREATICODUODENECTOMY FOR MALIGNANCY? Oral poster presentation North Texas Chapter American of College of Surgeons Meeting, Dallas, TX, Feb 2010.
  31. Jeyarajah, D. Rohan; Khithani, Amit; Barton, Joshua; Galanopoulos, Christos; Curtis, David; Rassadi, Roozbeh. THE "WHIP-STOW" PROCEDURE: AN INNOVATIVE MODIFICATION TO THE PANCREATICOJEJUNAL ANASTOMOSIS. Oral video presentation. 9 TH World Congress of the IHBPA, Buenos Aires, Argentina, April 2010.
  32. Amit Khithani, MBBS; Kevin Lowe, Derick Christian, MD; D. Rohan Jeyarajah, MD. Neoadjuvant Chemoradiotherapy for esophageal cancer: It works. Oral presentation North Texas Chapter American of College of Surgeons Meeting, Dallas, TX, Feb 2011.
  33. Kevin Lowe, Amit Khithani, MBBS; Derick Christian, MD; D. Rohan Jeyarajah, MD. DOES THOROCOSCOPY INCREASE LYMPH NODE CLEARANCE IN MINIMALLY INVASIVE ESOPHAGECTOMY? Oral presentation North Texas Chapter American of College of Surgeons Meeting, Dallas, TX, Feb 2011.
  34. Amit Khithani, MBBS; Kevin Lowe, Derick Christian, MD; D. Rohan Jeyarajah, MD. Keeping it with the Surgeons: Esophagectomies for Barrett's with high grade dysplasia. Oral presentation North Texas Chapter American of College of Surgeons Meeting, Dallas, TX, Feb 2011.
  35. Kevin Lowe,  Amit Khithani, MBBS; Derick Christian, MD; D. Rohan Jeyarajah, MD. GALL BLADDER CANCER DIAGNOSED WITHOUT CHOLECYSTECTOMY: AUTOMATIC REFERAL TO A HEPATOBILIARY SURGEON? Oral presentation North Texas Chapter American of College of Surgeons Meeting, Dallas, TX, Feb 2011.
  36. Kevin Lowe, Amit Khithani, MBBS; Derick Christian, MD; D. Rohan Jeyarajah, MD. DOES THE PRESENCE OF METASTATIC LYMPH NODES PREDICT MARGIN POSITIVE RESECTION IN PANCREATIC CANCER? Oral presentation North Texas Chapter American of College of Surgeons Meeting, Dallas, TX, Feb 2011.
  37. Kevin Lowe, Amit Khithani, MBBS; Derick Christian, MD; D. Rohan Jeyarajah, MD. GALL BLADDER CANCER DIAGNOSED WITHOUT CHOLECYSTECTOMY: AUTOMATIC REFERAL TO A HEPATOBILIARY SURGEON? Oral presentation. Annual Meeting of the AHBPA Miami Beach, March 2011.
  38. Siripurapu, V, Liu, E, Khithani, A, Mejia, A, Dickerman, R, Jeyarajah, DR. Tumor Location in Pancreatic Cancer Influences Lymph Node Positivity. (Oral Presentation) North Texas Chapter-ACS, February 2012.
  39. Siripurapu, V, Liu, E, Khithani, A, Winston, T, Jeyarajah, DR. A Surgeon's Learning Experience of Pancreaticoduodenectomies (PD): It Continues Despite a Decade Long Experience. (Mini Talk) North Texas Chapter-ACS, February 2012.
  40. Siripurapu, V, Liu, E, Khithani, A, Winston, T, R, Jeyarajah, DR. Superior Mesenteric Vein (SMV) Margin Positivity in Resectable Pancreatic Cancer Correlates with High Superior Mesenteric Artery (SMA) Margin Positivity; Is Vein Resection Advisable? (Oral Presentation) North Texas Chapter-ACS, February 2012.
  41. Siripurapu, V, Mekala, A, Liu, E, Jeyarajah, DR. Preoperative Chemotherapy in High Risk Gastric Cancer. No Guarantee of Downstaging but remains our best MAGIC bullet. (Oral Presentation) North Texas Chapter-ACS, February 2012.
  42. Jeyarajah, DR. Hiatal Hernia Repair. (Oral Video) North Texas Chapter-ACS, February 2012.
  43. Osman, H, Thomas, A, Jeyarajah, DR. Not All Nodes Are the Same: Nodal Stations Variability in Pancreaticoduodenectomy (PD) and Role In Decision Making. (Oral Scientific Presentation) North Texas Chapter-ACS. February 2013.
  44. Osman, H, Thomas, A, Jeyarajah, DR. Body Mass Index (BMI): Does It Make a Difference in Pancreaticoduodenectomy Outcome? (Oral Scientific Presentation) North Texas Chapter-ACS. February 2013.
  45. Osman, H, Rice, M, Winston, T, Thomas, A, Jeyarajah, DR. Preoperative Chemotherapy Results in Unpredictable Response in Gastric Cancer: No Magic Bullet. (Mini Talk) North Texas Chapter-ACS. February 2013.
  46. Osman, H, Winston, T, Thomas, A, Majid, A, Shahin, I, Van Meter, T, Jeyarajah, DR. Selective Internal Radiation Therapy (SIRT) Using Yttrium-90 in Atypical Liver Tumors; Single Center Experience. (Oral Scientific Presentation) North Texas Chapter-ACS. February 2013.
  47. Osman, H, Parikh, J, Patel, S, Jeyarajah, DR. Are general surgery residents adequately prepared for hepatopancreaticobiliary (HPB) fellowships? Questionnaire based study (Oral Poster Presentation) AHPBA 2014.
  48. Osman, H, Jeyarajah, DR. The current state of HPB fellowship experience in North America (Oral Poster Presentation) AHPBA 2014.

POSTER SESSIONS

  1. Gerhardt TC, Levy MF, Goldstein RM, Abbasoglu O, Testa G, Jeyarajah DR, Husberg BS, Gonwa TA, Klintmalm GB.  Employment/Volunteerism among adults undergoing liver transplantation for Laennec's cirrhosis. Liver transplantation for alcoholic liver disease, Bethesda, Maryland, December 1996.
  2. Crews KA, Levy MF, Jenevein B, Nowel BL, Jeyarajah DR, Testa G, Abbasoglu O, Goldstein RM, Husberg BS, Gonwa TA, Klintmalm GB.  Neurologic death following liver transplantation.  American Society of Transplant Physicians: 16th Annual Meeting, Chicago, IL, May 1997.
  3. Gerhardt TC, Goldstein RM, Levy MF, Husberg BS, Testa G, Abbasoglu O, Jeyarajah DR, Gonwa TA, Klintmalm GB.  Alcohol use among patients transplanted for alcoholic cirrhosis.  American Society of Transplant Physicians: 16th Annual Meeting, Chicago, IL, May 1997.
  4. Jeyarajah, DR, Kielar M, Lindberg G, Gokasian ST, Lu CY.  FAS Ameliorates Cerulein-Induced Pancreatitis (AP). (Poster presentation). Third Biennial Americas Hepatopancreatobiliary Congress, Miami Beach, FL, February 2001.
  5. Jeyarajah DR, Kielar ML, Frantz N, Zhang Y, Woodward V, Lu CY.  Acute bile duct ligation impairs hepatic clearance of bacteria by induction of maladaptive cytokines.  Poster presentation. AAS 36th Annual Meeting. Boston MA, Nov 2002.
  6. Jeyarajah DR, Kielar ML, Devraj S, Lu CY.  Bile Duct Ligation (BDL) results in increased liver IL-10 production and protection against renal ischemia in mice.  American Society of Transplantation: 18th Annual Meeting, Chicago, IL, May 1999.
  7. Jeyarajah DR, Kielar M, Frantz N, Lu CY. Interleukin 10, produced in response to biliary obstruction and hepatic infection, is protective.  AAS 37th Annual Meeting. Sacramento, CA. 2003.
  8. Jeyarajah DR, Kielar ML, Zhon X, Frantz NL, Karimi P, John R, Lu CY.  A Role Model of Cholangitis Results in neutropinel recruitment by MIP2.  Poster presentation at Surgical Infection Society.  Indianapolis, IN, April 2004.
  9. Karimi P, Jeyarajah DR, Bhagat V, Keilar ML, Bennett M, Gokasian T, Lu CY. Ineffective Macrophage Response in the Peritoneal Cavity of Neonatal Mice may lead to Cerebral Listeriosis: Role of Monocyte Chemoattractant Protein-1.  UT Southwestern Medical Center.  Dallas, TX, Feb 2005.
  10. Shabout NM, Hamilton L, Rege RV, Jeyarajah DR. Cysts in the pancreas: how good is Computer Tomography in diagnosis?  Poster presentation at American Hepato-Pancreato-Biliary Association Annual Congress. Ft. Lauderdale, FL, April 2005.
  11. Jeyarajah DR, Kielar ML, John R, Karimi P, Lu CY.  Impact of bile duct ligation on portal venous infection with E. coli: role of interleukin 10.  Poster presentation at American Hepato-Pancreato-Biliary Association Annual Congress. Ft. Lauderdale, FL, April 2005.
  12. David Curtis M.D, Amit Khithani MBBS, Maggie White RN, D. Rohan Jeyarajah MD. No ICU post pancreaticoduodenectomy: A reality, even with debilitated patients. SSO Phoenix AZ, March 2009.
  13. David Curtis MD, Amit Khithani MBBS, Allison Vo RN, D. Rohan Jeyarajah MD. Pancreaticoduodenectomy (PD) at a non university tertiary care center (NUTCC).Outcomes and feasibility. SSO Phoenix AZ, March 2009.
  14. David Curtis MD, Amit Khithani MBBS, John Jay MD, Allison Vo RN, D. Rohan Jeyarajah MD. Feasibility of performing minimally invasive esophagectomy (MIE) at anon university tertiary training center (NUTTC). SSO Phoenix AZ, March 2009.
  15. Amit S Khithani, MBBS, David E Curtis, MD, Maggie White, RN, D. Rohan Jeyarajah, MD. Reducing ICU admissions in higher ASA class patients after pancreaticoduodenectomy: Impact of a team based approach. AHBPA Miami Beach, April 2009.
  16. David Curtis, MD, Amit Khithani, MBBS, A. Joe Saad, MD, D. Rohan Jeyarajah, MD. Margin status with a standardized protocol for the sectioning of pancreaticoduodenectomy specimens. AHBPA Miami Beach, April 2009.
  17. Amit Khithani, MBBS, David Curtis, MD, A. Joe Saad, MD, Jeffrey D. Linder, MD, Paul Tarnasky MD, D. Rohan Jeyarajah, MD. Malignant potential in Intraductal Papillary Mucinous Neoplasm (IPMN): Why observe? AHBPA Miami Beach, April 2009.
  18. David Curtis, MD, Amit Khithani, MBBS, Kesha Henderson MD, Alejandro Mejia MD, Stephen Cheng MD, D. Rohan Jeyarajah, MD. Gallbladder cancer- still a bad disease. AHBPA Miami Beach, April 2009.
  19. David Curtis, MD, Amit Khithani, MBBS, MD, D. Rohan Jeyarajah, MD. Gallbladder cancer found after laparoscopic cholecystectomy: Is port site excision necessary? DDW, Chicago, May 2009.
  20. Amit Khithani, MBBS, David E Curtis, MD, Christos Galanopoulos MD , John Jay MD, D. Rohan Jeyarajah, MD. Minimally invasive esophagectomies (MIE) at a non university tertiary care center (NUTTC): Feasibility and outcomes. DDW, Chicago, May 2009.
  21. Amit S Khithani, MBBS, David E Curtis, MD, Christos Galanopoulos MD, D. Rohan Jeyarajah, MD. Pancreaticoduodenectomy (PD) at a non university tertiary care center (NUTCC): Outcomes and feasibility. DDW, Chicago, May 2009.
  22. Amit S Khithani, MBBS, David E Curtis, MD, A. Joe Saad, MD, D. Rohan Jeyarajah, MD. An aggressive approach to pancreaticoduodenectomy (PD)– Surgeon's clinical suspicion matters. DDW, Chicago, May 2009.
  23. Derick Christian, Amit Khithani, MBBS; Joshua Barton, MD; D. Rohan Jeyarajah, MD. THE "WHIP-STOW" PROCEDURE: AN INNOVATIVE MODIFICATION TO THE PANCREATICOJEJUNAL ANASTOMOSIS. Oral poster presentation North Texas Chapter American of College of Surgeons Meeting Dallas, TX, Feb 2010.
  24. Derick Christian MD, Amit Khithani, MBBS;, Joshua Barton, MD; D. Rohan Jeyarajah, MD. Comorbidites should not preclude resection in Esophageal cancer: The role of Minimal Invasive Esophagectomy: SSO, March 2010. 
  25. Amit Khithani, MBBS; Derick Christian MD, Joshua Barton, MD; D. Rohan Jeyarajah, MD. Oncologic efficacy of minimally invasive esophagectomy (MIE) after neoadjuvant chemoradiotherapy (NT) in esophageal cancer. SSO, March 2010.
  26. Amit Khithani, MBBS; Derick Christian Joshua Barton, MD; D. Rohan Jeyarajah, MD. Counseling with the pathologist: Impacting node retrieval in pancreaticoduodenectomy for malignancy? 9 TH World Congress of the IHBPA, Buenos Aires, Argentina, April 2010.
  27. Derick Christian MD, Amit Khithani, MBBS;, Joshua Barton, MD; D. Rohan Jeyarajah, MD. Lymph node metastasis in pancreatic endocrine tumors: size does matter. 9TH World Congress of the IHBPA, Buenos Aires, Argentina, April 2010.
  28. Amit Khithani, MBBS; Derick Christian Joshua Barton, MD; D. Rohan Jeyarajah, MD. Multivisceral resections with Pancreaticoduodenectomy: Only after careful patient selection. 9 TH World Congress of the IHBPA, Buenos Aires, Argentina, April 2010.
  29. Derick Christian MD, Amit Khithani, MBBS; Joshua Barton, MD; D. Rohan Jeyarajah, MD. Liver Transection with Microwave technology: A novel technique. DDW, New Orleans, May 2010.
  30. Derick Christian MD, Amit Khithani, MBBS; Joshua Barton, MD; D. Rohan Jeyarajah, MD. Will Ki-67 predict lymph node status in pancreatic endocrine tumors? DDW, May 2010, New Orleans.
  31. Kevin Lowe, Amit Khithani, MBBS; Derick Christian, MD; D. Rohan Jeyarajah, MD. Does the presence of metastatic lymph nodes predict margin positive resection in pancreatic cancer. Poster presentation North Texas Chapter American of College of Surgeons Meeting Dallas, TX, Feb 2011.
  32. Kevin Lowe, Amit Khithani, MBBS; Derick Christian, MD; D. Rohan Jeyarajah, MD. CURATIVE RESECTION IN GALLBLADDER CANCER: DOES NODE STATUS PREDICT RESECTABILITY? Poster presentation North Texas Chapter American of College of Surgeons Meeting Dallas, TX, Feb 2011.
  33. Kevin Lowe, Amit Khithani, MBBS; Derick Christian, MD; D. Rohan Jeyarajah, MD.Does the presence of metastatic lymph nodes predict margin positive resection in pancreatic cancer. Poster presentation North Texas Chapter American of College of Surgeons Meeting Dallas, TX, Feb 2011.
  34. Kevin Lowe, Amit Khithani, MBBS; Derick Christian, MD; D. Rohan Jeyarajah, MD. CURATIVE RESECTION IN GALLBLADDER CANCER: DOES NODE STATUS PREDICT RESECTABILITY? Poster presentation North Texas Chapter American of College of Surgeons Meeting Dallas, TX, Feb 2011.
  35. Amit Khithani, MBBS; Kevin Lowe, Derick Christian, MD; D. Rohan Jeyarajah, MD.Keeping it with the Surgeons: Esophagectomies for Barrett's with high grade dysplasia. SSO San Antonio TX, March 2011.
  36. A. Khithani, K. Lowe, D. Christian, A. Mejia, D. Rohan Jeyarajah. PANCREATICODUODENECTOMY (PD) COMPLICATES MULTIVISCERAL RESECTIONS IN HEPATOPANCREATOBILIARY SURGERY. Annual Meeting of the AHBPA Miami Beach, March 2011.
  37. A. Khithani, K. Lowe, D. J. Christian, D. Rohan Jeyarajah. PANCREATICOJEJUNAL ANASTOMOTIC STRICTURES: WHY REVISE WHEN THERE'S A PANCREATICOGASTROSTOMY Annual Meeting of the AHBPA Miami Beach, March 2011.
  38. K. Lowe, A. Khithani, D. Christian, D. Rohan Jeyarajah. DOES THE PRESENCE OF METASTATIC LYMPH NODES PREDICT MARGIN POSITIVE RESECTION IN PANCREATIC CANCER? Annual Meeting of the AHBPA Miami Beach, March 2011.
  39. K. Lowe, A. Khithani, D. Christian, D.Rohan Jeyarajah. MARGIN STATUS AFTER PANCREATODUODENECTOMY FOR PERIAMPULLARY AND HEAD OF PANCREAS TUMORS: ANATOMY OR TUMOR BIOLOGY? Annual Meeting of the AHBPA Miami Beach, March 2011.
  40. Siripurapu, V, Liu, E, Winston, T, Jeyarajah, DR. Pancreaticoduodenectomies in High Volume Centers; Direct transfer to floor improves Length of Stay without affecting morbidity or mortality. (Poster Presentation) North Texas Chapter-ACS, February 2012.
  41. Siripurapu, V, Winston, T, Liu, E, Jeyarajah, DR. Referral Patterns in Pancreatic Cancer to a High Volume Center; The Gastroenterologist Remains Your Friend. (Poster Presentation) North Texas Chapter-ACS, February 2012.
  42. Siripurapu, V, Liu, E, Khithani, A, Mejia, A, Dickerman, R, Jeyarajah, DR. Tumor Location in Pancreatic Cancer Influences Lymph Node Positivity. (Oral Poster Presentation) AHPBA, March 2012.
  43. Siripurapu, V, Liu, E, Khithani, A, Winston, T, R, Jeyarajah, DR. Superior Mesenteric Vein (SMV) Margin Positivity in Resectable Pancreatic Cancer Correlates with High Superior Mesenteric Artery (SMA) Margin Positivity; Is Vein Resection Advisable? (Oral Poster Presentation) AHPBA, March 2012.
  44. Siripurapu, V, Winston, T, Liu, E, Jeyarajah, DR. Referral Patterns in Pancreatic Cancer to a High Volume Center; The Gastroenterologist Remains Your Friend. (Oral Poster Presentation) AHPBA, March 2012.
  45. Siripurapu, V, Liu, E, Khithani, A, Winston, T, Jeyarajah, DR. A Surgeon's Learning Experience of Pancreaticoduodenectomies (PD): It Continues Despite a Decade Long Experience. (Oral Poster Presentation) AHPBA, March 2012.
  46. Siripurapu, V, Jeyarajah, DR. How To Do a Whipple in Approximately Three Hours: Separation of the Right Colon Mesentery to Find the SMV and the Concept of the Mesopancreas. (Oral Poster Presentation) AHPBA, March 2012.
  47. Siripurapu, V, Jeyarajah, DR. Methodist Dallas Medical Center HPB Fellowship. (Oral Poster Presentation) AHPBA, March 2012.
  48. Osman, H, Thomas, A, Jeyarajah, DR. The Need for Jejunal Feed or TPN After Pancreaticoduodenectomy (PD): Is It Predictable? (Oral Poster Presentation) AHPBA. February 2013.
  49. Osman, H, Thomas, A, Jeyarajah, DR. The Need for Jejunal Feed or TPN After Pancreaticoduodenectomy (PD): Is It Predictable? (Poster Presentation) North Texas Chapter-ACS. February 2013.
  50. Osman, H, Thomas, A, Jeyarajah, DR. Not All Nodes Are the Same: Nodal Stations Variability in Pancreaticoduodenectomy (PD) and Role In Decision Making. (Oral Poster Presentation) AHPBA. February 2013.
  51. Osman, H, Thomas, A, Jeyarajah, DR. Intraoperative Estimated Blood Loss Predicts Need for ICU Care: A Single Center Experience. (Oral Poster Presentation) AHPBA. February 2013.
  52. Osman, H, Thomas, A, Jeyarajah, DR. Intraoperative Estimated Blood Loss Predicts Need for ICU Care: A Single Center Experience. (Poster Presentation) North Texas Chapter-ACS. February 2013.
  53. Osman, H, Thomas, A, Jeyarajah, DR. Body Mass Index (BMI): Does It Make a Difference in Pancreaticoduodenectomy Outcome? (Oral Poster Presentation) AHPBA. February 2013.
  54. Osman, H, Jeyarajah, DR. Hepato-Pancreato-Biliary (HPB) Surgery Fellows: What is After Fellowship? A Single Fellowship Experience (Oral Poster Presentation) AHPBA. February 2013.
  55. Osman, H, Liu, E, Siripurapu, V, Winston, T, Jeyarajah, DR. Alvimopan Patients Show Significant Improvement in Recovery Post Pancreaticoduodenectomy Surgeries. (Poster Presentation) North Texas Chapter – ACS. February 2013.
  56. Patel, S, Cheek, S, Osman, H, Jeyarajah, DR. Transhiatal vs. Three- Hole Esophagectomy: Does Technique change Survival? (Poster Session) 54th Annual Meeting in conjunction with DDW, Chicago, IL. May 2014.
  57. Osman, H, Parikh, J, Patel, S, Jeyarajah, DR. Are general surgery residents adequately prepared for hepatopancreaticobiliary (hpb) fellowships? Questionnaire based study (Oral Poster Presentation) AHPBA 2014.
  58. Cheek, S, Patel, S, Osman, H, Jeyarajah, DR. The benefits of laparoscopic pancreatectomy: it does make a difference (Oral Poster Presentation) AHPBA 2014.
  59. Cheek, S, Patel, S, Osman, H, Jeyarajah, DR. Differences in outcomes in pancreaticoduodenectomy (PD) in the modern era: does a malignant diagnosis make a difference? (Oral Poster Presentation) AHPBA 2014.
  60. Cheek, S, Patel, S, Osman, H, Jeyarajah, DR. Concept of the mesopancreas: coining a new surgical anatomical space (Oral Poster Presentation) AHPBA 2014.
  61. Patel, S, Cheek, S, Winston, T, Osman, H, Jeyarajah, DR. Is there a "July effect" for HPB cases? (Oral Poster Presentation) AHPBA 2014.
  62. Patel, S, Cheek, S, Winston, T, Osman, H, Jeyarajah, DR. Incidental gallbladder cancer on cholecystectomy: is there more than meets the eye? (Oral Poster Presentation) AHPBA 2014.
  63. Osman, H, Jeyarajah, DR. The current state of HPB fellowship experience in North America (Oral Poster Presentation) AHPBA 2014.